(Q64944387)

1 July 2019

title

Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice. (English)

1 reference

1 July 2019

author name string

Melinda Przetak

1

1 reference

1 July 2019

Jesse Chow

2

1 reference

1 July 2019

Hongsheng Cheng

3

1 reference

1 July 2019

Jeffrey Rose

4

1 reference

1 July 2019

Lynn D Hawkins

5

1 reference

1 July 2019

Sally T Ishizaka

6

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 July 2019

published in

Vaccine

1 reference

1 July 2019

volume

21

1 reference

1 July 2019

issue

9-10

1 reference

1 July 2019

page(s)

961-970

1 reference

1 July 2019

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Induction of direct antimicrobial activity through mammalian toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Regulation of Toll-like receptors in human monocytes and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Targeting immune response induction with cochleate and liposome-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Phase I study of recombinant human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

Interleukin-12: role of interferon-gamma in IL-12 adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900737-5

7 January 2021

10.1016/S0264-410X(02)00737-5

Identifiers

DOI

1 reference

1 July 2019

1 reference

1 July 2019